Estrella Immunopharma ESLA
NASDAQ ESLA
$0.70 +0.15 (+26.38%)
As of: Oct 22, 2026 · 1:15 PM EDT

Estrella Immunopharma (ESLA) Notes Payables (2022 - 2023)

Updated

Estrella Immunopharma (ESLA) reported Notes Payables of $300,000 for Q1 2024, up 9.9% from the prior quarter.

Analysis

Estrella Immunopharma (ESLA) Notes Payables (2022 - 2023) Analysis & Trends

At the end of FY2023, Estrella Immunopharma posted Notes Payables of $273,066.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn
10 Estrella Immunopharma 29.94 Mn 24.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 300,000.00
Jun 30, 2023 273,066.00
Mar 31, 2023 136,533.00
Sep 30, 2022 498,600.00
API Access

Estrella Immunopharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ESLA&period=max&api_key=YOUR_API_KEY